preladenant

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

adjunctive treatment of Parkinson's disease (investigational)

Mechanism of action

inhibits adenosine A2A receptors

More general terms

adenosine A2A receptor antagonist

References

↑ Hauser RA et al. Preladenant in patients with Parkinson's disease and motor fluctuations: A phase 2, double-blind, randomised trial. Lancet Neurol 2011 Mar; 10:221. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21315654

Database

PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=10117987

Retrieved from "https://aaushi.info/w/index.php?title=A26063&oldid=971479"

↑ Back to top